Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Nov-21 10:04 AM View:  | Flexion Therapeutics, Inc. (FLXN) | 19-Nov-21 | Disposition | 140,843 | $8.50 | $1,197,170.00 | (96%) 146.84K to 6.0K | (7%) |
| 19-Nov-21 10:04 AM View: | Flexion Therapeutics, Inc. (FLXN) | 19-Nov-21 | Disposition | 6,000 | $8.50 | $51,000.00 | (100%) 6.0K to 0 | (7%) |
| 20-Jul-21 8:49 PM View: | Flexion Therapeutics, Inc. (FLXN) | 19-Jul-21 | Market Sale | 3,944 | $6.45 | $25,438.80 | (3%) 150.31K to 146.36K | (42%) |
| 28-Jun-21 6:09 PM View: | Flexion Therapeutics, Inc. (FLXN) | 21-Jun-21 | Grant | 539 | $7.78 | $4,193.42 | < 1% 149.77K to 150.31K | |
| 03-Mar-21 6:35 PM View: | Flexion Therapeutics, Inc. (FLXN) | 01-Mar-21 | Grant | 30,000 | -- | -- | 25% 119.77K to 149.77K | |
| 07-Jan-21 5:56 PM View: | Flexion Therapeutics, Inc. (FLXN) | 05-Jan-21 | Market Sale | 6,829 | $11.13 | $76,006.80 | (5%) 126.6K to 119.77K | 18% |
| 20-Jul-20 9:23 PM View: | Flexion Therapeutics, Inc. (FLXN) | 16-Jul-20 | Grant | 38,750 | -- | -- | 44% 87.43K to 126.18K | |
| 24-Jun-20 4:09 PM View: | Flexion Therapeutics, Inc. (FLXN) | 22-Jun-20 | Grant | 369 | $10.83 | $3,996.27 | < 1% 87.06K to 87.43K | 4% |
| 03-Mar-20 4:18 PM View: | Flexion Therapeutics, Inc. (FLXN) | 02-Mar-20 | Grant | 31,000 | -- | -- | 55% 56.06K to 87.06K | |
| 07-Jan-20 4:33 PM View: | Flexion Therapeutics, Inc. (FLXN) | 03-Jan-20 | Sale | 3,724 | -- | -- | (6%) 59.78K to 56.06K | |
| 08-Oct-19 4:27 PM View: | Flexion Therapeutics, Inc. (FLXN) | 07-Oct-19 | Payment of Exercise | 1,002 | $13.98 | $14,008.00 | (2%) 60.4K to 59.39K | 35% |
| 08-Oct-19 4:27 PM View: | Flexion Therapeutics, Inc. (FLXN) | 06-Oct-19 | Option Exercise | 3,400 | -- | -- | 6% 57.0K to 60.4K | |
| 24-Jun-19 4:13 PM View: | Flexion Therapeutics, Inc. (FLXN) | 21-Jun-19 | Grant | 389 | $9.81 | $3,816.09 | < 1% 56.61K to 57.0K | |
| 05-Mar-19 6:18 PM View: | Flexion Therapeutics, Inc. (FLXN) | 01-Mar-19 | Grant | 36,000 | -- | -- | 175% 20.61K to 56.61K | |
| 04-Jan-19 5:10 PM View: | Flexion Therapeutics, Inc. (FLXN) | 03-Jan-19 | Market Sale (Planned) | 622 | $12.36 | $7,687.92 | (3%) 17.83K to 17.21K | 26% |
| 09-Oct-18 4:30 PM View: | Flexion Therapeutics, Inc. (FLXN) | 08-Oct-18 | Payment of Exercise | 1,002 | $18.60 | $18,637.20 | (5%) 18.48K to 17.48K | 51% |
| 22-Jun-18 4:37 PM View: | Flexion Therapeutics, Inc. (FLXN) | 20-Jun-18 | Acquisition (other) | 171 | $21.22 | $3,628.62 | < 1% 18.31K to 18.48K | (45%) |
| 02-Feb-18 4:48 PM View: | Flexion Therapeutics, Inc. (FLXN) | 01-Feb-18 | Grant | 8,333 | -- | -- | 84% 9.97K to 18.31K | |
| 28-Feb-14 4:16 PM View: | Antigenics Inc. (AGEN) | 26-Feb-14 | Market Sale (Planned) | 5,000 | $5.00 | $25,000.00 | (8%) 62.41K to 57.41K | 27% |
| 29-Jan-13 10:25 AM View: | Antigenics Inc. (AGEN) | 28-Jan-13 | Grant | 694 | $4.35 | $3,018.90 | 2% 36.72K to 37.41K | (16%) |
| 29-Oct-12 4:41 PM View: | Antigenics Inc. (AGEN) | 26-Oct-12 | Grant | 695 | $4.42 | $3,071.90 | 2% 36.02K to 36.72K | (17%) |
| 14-Sep-12 3:27 PM View: | Antigenics Inc. (AGEN) | 12-Sep-12 | Grant | 5,044 | -- | -- | 16% 30.98K to 36.02K | |
| 30-Jul-12 2:14 PM View: | Antigenics Inc. (AGEN) | 26-Jul-12 | Grant | 694 | $4.61 | $3,199.34 | 2% 30.28K to 30.98K | (21%) |
| 21-Jun-12 5:00 PM View: | Antigenics Inc. (AGEN) | 21-Jun-12 | Disposition | 14,784 | $5.05 | $74,659.20 | (33%) 45.07K to 30.28K | 28% |
| 21-Jun-12 5:00 PM View: | Antigenics Inc. (AGEN) | 20-Jun-12 | Disposition | 14,151 | $4.99 | $70,613.50 | (24%) 59.22K to 45.07K | 27% |
| 21-Jun-12 5:00 PM View: | Antigenics Inc. (AGEN) | 19-Jun-12 | Grant | 14,153 | $5.26 | $74,444.80 | 31% 45.06K to 59.22K | (30%) |
| 30-Apr-12 2:08 PM View: | Antigenics Inc. (AGEN) | 26-Apr-12 | Grant | 695 | $6.43 | $4,468.85 | 2% 44.37K to 45.06K | (43%) |
| 16-Mar-12 2:27 PM View: | Antigenics Inc. (AGEN) | 15-Mar-12 | Grant | 6,077 | $5.31 | $32,268.90 | 16% 38.29K to 44.37K | (31%) |
| 31-Jan-12 8:51 AM View: | Antigenics Inc. (AGEN) | 26-Jan-12 | Grant | 694 | $2.76 | $1,915.44 | 2% 37.6K to 38.29K | 33% |
| 05-Jan-12 2:59 PM View: | Antigenics Inc. (AGEN) | 03-Jan-12 | Grant | 22,121 | $2.17 | $48,002.60 | 143% 15.48K to 37.6K | 69% |
| 29-Dec-11 4:25 PM View: | Antigenics Inc. (AGEN) | 29-Dec-11 | Market Sale | 8,939 | $2.01 | $17,967.40 | (37%) 24.42K to 15.48K | (82%) |
| 29-Dec-11 4:25 PM View: | Antigenics Inc. (AGEN) | 28-Dec-11 | Market Sale | 1,893 | $2.09 | $3,956.37 | (7%) 26.31K to 24.42K | (75%) |
| 29-Dec-11 4:25 PM View: | Antigenics Inc. (AGEN) | 27-Dec-11 | Market Sale | 3,156 | $2.14 | $6,753.84 | (11%) 29.46K to 26.31K | (71%) |
| 23-Dec-11 5:21 PM View: | Antigenics Inc. (AGEN) | 23-Dec-11 | Market Sale | 886 | $2.20 | $1,946.81 | (3%) 30.35K to 29.46K | (67%) |
| 23-Dec-11 5:21 PM View: | Antigenics Inc. (AGEN) | 22-Dec-11 | Market Sale | 1,716 | $2.19 | $3,758.55 | (5%) 32.07K to 30.35K | (67%) |
| 23-Dec-11 5:21 PM View: | Antigenics Inc. (AGEN) | 21-Dec-11 | Market Sale | 3,414 | $2.24 | $7,640.53 | (10%) 35.48K to 32.07K | (64%) |
| 28-Oct-11 11:05 AM View: | Antigenics Inc. (AGEN) | 26-Oct-11 | Grant | 695 | $2.70 | $1,876.50 | 2% 34.79K to 35.48K | 36% |
| 13-Sep-11 12:58 PM View: | Antigenics Inc. (AGEN) | 12-Sep-11 | Grant | 5,000 | $0.55 | $2,750.00 | 2% 203.72K to 208.72K | 11% |
| 28-Jul-11 12:06 PM View: | Antigenics Inc. (AGEN) | 26-Jul-11 | Grant | 4,166 | $0.79 | $3,291.14 | 2% 199.55K to 203.72K | (26%) |
| 28-Apr-11 12:22 PM View: | Antigenics Inc. (AGEN) | 26-Apr-11 | Grant | 4,167 | $0.92 | $3,833.64 | 2% 195.38K to 199.55K | (36%) |
| 11-Mar-11 10:01 AM View: | Antigenics Inc. (AGEN) | 09-Mar-11 | Grant | 18,233 | $0.98 | $17,868.30 | 10% 177.15K to 195.38K | (40%) |
| 28-Jan-11 10:29 AM View: | Antigenics Inc. (AGEN) | 26-Jan-11 | Grant | 4,167 | $0.95 | $3,958.65 | 2% 172.98K to 177.15K | (36%) |
| 20-Jan-11 5:09 PM View: | Antigenics Inc. (AGEN) | 20-Jan-11 | Grant | 28,895 | $0.94 | $27,161.30 | 20% 144.09K to 172.98K | (35%) |
| 28-Oct-10 3:04 PM View: | Antigenics Inc. (AGEN) | 26-Oct-10 | Grant | 4,165 | $0.98 | $4,081.70 | 3% 144.09K to 148.25K | (38%) |
| 28-Oct-10 3:04 PM View: | Antigenics Inc. (AGEN) | 26-Oct-10 | Market Sale (Planned) | 4,165 | $0.97 | $4,040.05 | (3%) 148.25K to 144.09K | 38% |
| 14-Sep-10 2:38 PM View: | Antigenics Inc. (AGEN) | 14-Sep-10 | Market Sale | 1,453 | $0.91 | $1,315.11 | (< 1%) 145.54K to 144.09K | 35% |
| 14-Sep-10 2:38 PM View: | Antigenics Inc. (AGEN) | 10-Sep-10 | Grant | 5,000 | $0.93 | $4,650.00 | 4% 140.54K to 145.54K | (37%) |
| 28-Jul-10 11:45 AM View: | Antigenics Inc. (AGEN) | 26-Jul-10 | Grant | 4,167 | $0.79 | $3,291.93 | 3% 140.54K to 144.71K | (26%) |
| 28-Jul-10 11:45 AM View: | Antigenics Inc. (AGEN) | 26-Jul-10 | Market Sale (Planned) | 4,165 | $0.80 | $3,329.92 | (3%) 144.71K to 140.54K | 27% |
| 28-Apr-10 2:22 PM View: | Antigenics Inc. (AGEN) | 26-Apr-10 | Grant | 4,167 | $1.19 | $4,958.73 | 3% 140.54K to 144.7K | (50%) |